pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Gene Therapy (AAV) · news · pharmadog
← back to Gene Therapy (AAV)
News · Gene Therapy (AAV)
527
stories
Aug 11, 26
STAT+: Trump is counting on the health care industry to remake vaccines. It’s pushing back instead
stat
Aug 11, 26
Epicrispr, Infinimmune snag combined $165M in VC cash
biospace
Aug 11, 26
STAT+: Skylark Bio kicks off new gene therapy trial for deafness
stat
Aug 11, 26
IRBs have a problem. Can North Star’s nonprofit model save it?
stat
Aug 10, 26
Scribe’s Benjamin Oakes on a rare IPO and bringing CRISPR to the masses
biopharma dive
Aug 10, 26
BioMarin axes asset from $270M Inozyme takeover, ending run in rare metabolic indication
biospace
Aug 10, 26
From ex vivo to in vivo: Shaping the next generation of viral vector manufacturing
biospace
Aug 7, 26
Intellia finds genetic suspect for liver safety signals with ATTR gene therapy
biospace
Aug 7, 26
Ensoma sheds more staff, pauses preclinical programs to home in on lead gene therapy
fiercebiotech
Aug 6, 26
STAT+: Two FDA approvals — a new drug and a new vaccine
stat
Aug 6, 26
FDA approves Moderna’s mRNA flu vaccine
biopharma dive
Aug 6, 26
CROs vs. biotechs: Finding the right fit
biospace
Aug 5, 26
STAT+: Once again, child dies in gene-editing trial in China, rekindling debate on transparency and safety
stat
Aug 5, 26
Bespoke gene-editing outfit abandons lead program, cuts ‘several’ employees
biospace
Aug 5, 26
Chaotic adcomms threaten to derail FDA’s bid to renew trust after Makary, Prasad
biospace
Aug 5, 26
Lilly drops another gene therapy trial from $1B Prevail buyout
fiercebiotech
Aug 5, 26
Fresenius Kabi Issues Voluntary Nationwide Recall of One Lot of Morphine Sulfate Injection, USP in a Simplist® Prefilled Syringe Due to Labeling Mix-up
fda medwatch
Aug 4, 26
J&J pharma leader to retire; Krystal slumps on gene therapy miss
biopharma dive
Aug 3, 26
Biologics push CMOs/CDMOs to expand sterile fill-finish and prefilled syringe capacity
biospace
Aug 3, 26
5 companies advancing ATTR assets in the wake of Wainua’s fail
biospace
Jul 31, 26
Capricor CEO won’t rule out legal action against FDA after negative adcomm
biospace
Jul 31, 26
UniQure welcomes possible adcomm for Huntington’s asset as regulatory ‘jitters’ spread through biopharma
biospace
Jul 31, 26
Opinion: Limb girdle muscular dystrophy patients face a maddening reality
stat
Jul 30, 26
Replimune overcomes ‘messy data’ to secure positive adcomm vote for melanoma therapy
biospace
Jul 30, 26
J&J pays Sail $785M, charting course to possible in vivo CAR-T buyout
fiercebiotech
Jul 29, 26
FDA advisers vote against approval of Capricor’s DMD therapy in chaotic adcomm meeting
biospace
Jul 29, 26
FDA reviewers vote against approval of Capricor’s DMD therapy in chaotic adcomm meeting
biospace
Jul 29, 26
Capricor Duchenne cell therapy voted down by FDA panel
biopharma dive
Jul 29, 26
FDA adcomm shoots down Capricor's Duchenne cell therapy after meeting marked by statistical dispute
fiercebiotech
Jul 29, 26
Biotechs bring big launches and pharma rivalries into Q2 earnings period
biospace
← prev
page 12 of 18
next →